Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy
This study is currently recruiting participants.
Verified January 2013
by Takeda Global Research & Development Center, Inc.
Study NCT01568385 Information provided by Takeda Global Research & Development Center, Inc.
First Received on March 29, 2012. Last Updated on January 17, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Digestive System Diseases
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial
Takeda Pharmaceutical Company Limited
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers